PUBLICATIONS · 26929274
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2016 Apr 28
- First author
- Olombel G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Olombel G
- type
- Author
- name
- Guerin E
- type
- Author
- name
- Guy J
- type
- Author
- name
- Perrot JY
- type
- Author
- name
- Dumezy F
- type
- Author
- name
- de Labarthe A
- type
- Author
- name
- Bastie JN
- type
- Author
- name
- Legrand O
- type
- Author
- name
- Raffoux E
- type
- Author
- name
- Plesa A
- type
- Author
- name
- Wagner-Ballon O
- type
- Author
- name
- Cornet E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Olombel G
- type
- Author
- name
- Guerin E
- type
- Author
- name
- Guy J
- type
- Author
- name
- Perrot JY
- type
- Author
- name
- Dumezy F
- type
- Author
- name
- de Labarthe A
- type
- Author
- name
- Bastie JN
- type
- Author
- name
- Legrand O
- type
- Author
- name
- Raffoux E
- type
- Author
- name
- Plesa A
- type
- Author
- name
- Wagner-Ballon O
- type
- Author
- name
- Cornet E
- type
- Author
- bibliography ids
- nci-bib-e0c408ce3c02a61a544ae3e7
- book metadata
- content sha256
- c4df56b10d08b342f85791236d6d449f6ad7d42fb253543e8850943f1f28c0ab
- document type
- citation
- dois
- 10.1182/blood-2016-01-689976
- electronic publication date
- display
- 2016 Feb 29
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26929274
- immutable id
- pubmed:26929274@c4df56b10d08b342f85791236d6d449f6ad7d42fb253543e8850943f1f28c0ab
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 17
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2157-60
- volume
- 127
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26929274
- provenance
- batch id
- fe5a46c92522c34737e8
- provider
- NCBI PubMed ESummary
- record sha256
- 85f1a57c3af11a9e8aa9a2c2cac90290d08b2a0c85ef46191dc9aca0e02b28b3
- response sha256
- 2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
- retrieved at
- 2026-09-09T23:47:17.939307+00:00
- publication date
- display
- 2016 Apr 28
- precision
- day
- year
- 2016
- publication types
- Clinical Trial
- Letter
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.
Preserved source evidence · Not medical advice
Triangle